This review discusses the molecular mechanisms for PI3K–Wnt crosstalk in breast cancer, and how Wnt-targeted therapies have the potential to contribute to treatment regimens for breast cancers with PI3K dysregulation. Here, PIK3CD is linked to breast carcinoma.